BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rodriguez-Fernandez S, Almenara-Fuentes L, Perna-Barrull D, Barneda B, Vives-Pi M. A century later, still fighting back: antigen-specific immunotherapies for type 1 diabetes. Immunol Cell Biol 2021;99:461-74. [PMID: 33483995 DOI: 10.1111/imcb.12439] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Rodriguez-Calvo T, Johnson JD, Overbergh L, Dunne JL. Neoepitopes in Type 1 Diabetes: Etiological Insights, Biomarkers and Therapeutic Targets. Front Immunol 2021;12:667989. [PMID: 33953728 DOI: 10.3389/fimmu.2021.667989] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Tian J, Song M, Kaufman DL. Designing Personalized Antigen-Specific Immunotherapies for Autoimmune Diseases-The Case for Using Ignored Target Cell Antigen Determinants. Cells 2022;11:1081. [PMID: 35406645 DOI: 10.3390/cells11071081] [Reference Citation Analysis]